Latest healthtech and biotech deals
The largest from last week:
๐บ๐ธ Rivus Pharmaceuticals, a clinical-stage biopharmaceutical company dedicated to improving cardio-metabolic health, completed a $132M Series B financing led by RA Capital Management.
๐ฎ๐ณ Molbio Diagnostics, an India-based healthtech startup, has raised US$85M. The company has developed portable devices that can detect various diseases, such as tuberculosis (TB), hepatitis, HIV, dengue, and malaria. It can also perform real-time PCR tests for Covid-19 detection, according to a statement.
๐บ๐ธ MicroTransponder, a healthtech company focused on enhancing daily living for people suffering from neurological conditions that impair sensory and motor function, raised $73M in Series E funding. The company intends to use the funds for the market development of its FDA-approved Vivistim Paired VNS System, which uses vagus nerve stimulation (VNS) during rehabilitation therapy to improve upper limb function for stroke survivors.
๐บ๐ธ Los Angeles-based Aadio Bioscience, a public biopharmaceutical company focused on therapy for cancer, has raised $73M in a private placement equity financing.
Other notable deals from around the globe:
๐ฌ๐ง Pheon Therapeutics, a leading Antibody-Drug Conjugate (ADC) specialist developing next generation ADCs for a wide range of hard-to-treat cancers, closed a $68M Series A funding round.
๐บ๐ธ Sonendo, a leading dental technology company and developer of the GentleWaveยฎ System, announced a private placement of common stock and pre-funded warrants, resulting in gross proceeds of $63M.
๐ฉ๐ช Sanity Group, a Berlin, Germany-based healthcare company focused on cannabinoids and the endocannabinoid system, raised $38M in Series B funding.
๐บ๐ธ CraniUS, an R&D company focused on building groundbreaking treatments for patients with chronic brain disease, closed a $19M Series A fundraising round.
Read up on all the latest health deals in Dealroom.co